Roberta M Strigel1, Erin Bravo2, Amye J Tevaarwerk3, Bethany M Anderson4, Amy L Stella3, Heather B Neuman5. 1. Department of Radiology, University of Wisconsin, Madison, WI; Department of Medical Physics, University of Wisconsin, Madison, WI; Carbone Cancer Center, University of Wisconsin, Madison, WI. 2. Department of Radiology, University of Wisconsin, Madison, WI. 3. Carbone Cancer Center, University of Wisconsin, Madison, WI; Department of Medicine, University of Wisconsin, Madison, WI. 4. Carbone Cancer Center, University of Wisconsin, Madison, WI; Department of Human Oncology, University of Wisconsin, Madison, WI. 5. Carbone Cancer Center, University of Wisconsin, Madison, WI; Department of Surgery, University of Wisconsin, Madison, WI. Electronic address: neuman@surgery.wisc.edu.
Abstract
INTRODUCTION: Limited data exist to guide appropriate use of magnetic resonance imaging (MRI) screening in women with a personal history of breast cancer. We developed an algorithm to inform the use of MRI screening in patients with a personal history, implemented it, and evaluated initial implementation at our community and academic practice sites. PATIENTS AND METHODS: A multidisciplinary committee of providers developed the initial algorithm on the basis of available literature and consensus. To evaluate projected MRI utilization based on the initial algorithm and inform algorithm revision, charts of patients < 80 years of age diagnosed and treated in 2010 with stage 0-III breast cancer (n = 236) were reviewed. The revised algorithm was implemented into the electronic medical record (September 2013). Thirteen months after implementation (2014-2015), chart review of patients with a personal history of breast cancer who underwent screening MRI was performed to assess algorithm adherence. RESULTS: Before algorithm development, 9% (20/236) of patients received MRI screening (6 genetic mutation/family history, 4 occult primary, 8 young age/breast density, 2 unknown). Use of MRI screening was projected to increase to 25% with algorithm implementation. In postimplementation review, we identified 183 patients with a personal history of breast cancer who underwent screening MRI, with 94% algorithm adherence. CONCLUSION: We successfully developed and implemented an algorithm to guide MRI screening in patients with a personal breast cancer history. Clinicians can use this algorithm to guide patient discussions regarding the utility of MRI screening. Further prospective study, including cancer detection rates, biopsy rate, and mortality, are necessary to confirm the algorithm's usefulness.
INTRODUCTION: Limited data exist to guide appropriate use of magnetic resonance imaging (MRI) screening in women with a personal history of breast cancer. We developed an algorithm to inform the use of MRI screening in patients with a personal history, implemented it, and evaluated initial implementation at our community and academic practice sites. PATIENTS AND METHODS: A multidisciplinary committee of providers developed the initial algorithm on the basis of available literature and consensus. To evaluate projected MRI utilization based on the initial algorithm and inform algorithm revision, charts of patients < 80 years of age diagnosed and treated in 2010 with stage 0-III breast cancer (n = 236) were reviewed. The revised algorithm was implemented into the electronic medical record (September 2013). Thirteen months after implementation (2014-2015), chart review of patients with a personal history of breast cancer who underwent screening MRI was performed to assess algorithm adherence. RESULTS: Before algorithm development, 9% (20/236) of patients received MRI screening (6 genetic mutation/family history, 4 occult primary, 8 young age/breast density, 2 unknown). Use of MRI screening was projected to increase to 25% with algorithm implementation. In postimplementation review, we identified 183 patients with a personal history of breast cancer who underwent screening MRI, with 94% algorithm adherence. CONCLUSION: We successfully developed and implemented an algorithm to guide MRI screening in patients with a personal breast cancer history. Clinicians can use this algorithm to guide patient discussions regarding the utility of MRI screening. Further prospective study, including cancer detection rates, biopsy rate, and mortality, are necessary to confirm the algorithm's usefulness.
Authors: Norman F Boyd; Helen Guo; Lisa J Martin; Limei Sun; Jennifer Stone; Eve Fishell; Roberta A Jong; Greg Hislop; Anna Chiarelli; Salomon Minkin; Martin J Yaffe Journal: N Engl J Med Date: 2007-01-18 Impact factor: 91.245
Authors: Wendy B DeMartini; Laura Ichikawa; Bonnie C Yankaskas; Diana Buist; Karla Kerlikowske; Berta Geller; Tracy Onega; Robert D Rosenberg; Constance D Lehman Journal: J Am Coll Radiol Date: 2010-11 Impact factor: 5.532
Authors: David V Schacht; Ken Yamaguchi; Jessica Lai; Kirti Kulkarni; Charlene A Sennett; Hiroyuki Abe Journal: AJR Am J Roentgenol Date: 2014-02 Impact factor: 3.959
Authors: Roberta M Strigel; Jennifer Rollenhagen; Elizabeth S Burnside; Mai Elezaby; Amy M Fowler; Frederick Kelcz; Lonie Salkowski; Wendy B DeMartini Journal: Acad Radiol Date: 2016-12-13 Impact factor: 3.173
Authors: Allison W Kurian; Laura A McClure; Esther M John; Pamela L Horn-Ross; James M Ford; Christina A Clarke Journal: J Natl Cancer Inst Date: 2009-07-09 Impact factor: 13.506
Authors: Constance D Lehman; Janie M Lee; Wendy B DeMartini; Daniel S Hippe; Mara H Rendi; Grace Kalish; Peggy Porter; Julie Gralow; Savannah C Partridge Journal: J Natl Cancer Inst Date: 2016-01-07 Impact factor: 13.506